Additionally, screening of the AML/LPC immunopeptidomes for peptides derived from common AML-specific mutations (e.g. FLT3, NPM1, IDH2, DNMT3A) enabled the identification of naturally presented neoepitopes of NPM1 and IDH2. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.